Epclusa® is a once-daily single pill treatment for 12 weeks, with cure rates of more than 90% no matter which HCV genotype the person has.
“We welcome the announcement from Federal Health Minister Hunt that this new treatment will be subsidised so that it can be accessed by all Australians,” said Haemophilia Foundation Australia President Gavin Finkelstein.
“This last year has been a very exciting time for the bleeding disorders community. So many people are finally cured of their hep C with these new treatments – and with very few side-effects, if any. But there are still some people who haven’t had treatment yet.
“Treatments like this that are easy to prescribe and easy to take make it simpler for both the doctor and the person with hep C. This means that some people who live some distance away from the specialist centres can see their local doctor for their treatment.
“The Australian Government is committed to eliminating hep C in Australia by 2030 and we would like to achieve this much earlier in the bleeding disorders community. I urge all community members to take this opportunity to be cured. If you or someone you know with a bleeding disorder and hep C has something that is getting in the way of treatment, we invite you to speak to us so that we can find a solution together.”
For more information, visit the HFA World Hepatitis Day page.
Or contact HFA on:
T: 1800 807 173
E: hfaust@haemophilia.org.au